About
Implantable Neurological Treatments
Areas of Focus
Categories
Medical ImplantBiotech
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
1,293
By Phase
PHASE2: 3PHASE3: 2NA: 4PHASE4: 1
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 3RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05339126Lead Sponsor
RNS System LGS Feasibility Study
PHASE2Recruiting
24 participants
Started: Oct 4, 2022 · Completed: Dec 31, 2026
NCT05147571Lead Sponsor
RNS System NAUTILUS Study
PHASE3Active, not recruiting
100 participants
Started: Aug 9, 2022 · Completed: Mar 31, 2026
NCT04839601Lead Sponsor
RNS System RESPONSE Study
NATerminated
9 participants
Started: Oct 27, 2021 · Completed: May 1, 2025
NCT05120635Collaborator
Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
NARecruiting
80 participants
Started: Oct 1, 2021 · Completed: Jun 30, 2026
NCT03868670Collaborator
Responsive Neurostimulation For Loss Of Control Eating
NAActive, not recruiting
6 participants
Started: Apr 10, 2019 · Completed: Jan 1, 2026
Locations (1)
Headquarters
Mountain View, CA, United States
Map
Loading map...